Fountain, E.; Bassett, R.L.; Cain, S.; Posada, L.; Gombos, D.S.; Hwu, P.; Bedikian, A.; Patel, S.P.
Adjuvant Ipilimumab in High-Risk Uveal Melanoma. Cancers 2019, 11, 152.
https://doi.org/10.3390/cancers11020152
AMA Style
Fountain E, Bassett RL, Cain S, Posada L, Gombos DS, Hwu P, Bedikian A, Patel SP.
Adjuvant Ipilimumab in High-Risk Uveal Melanoma. Cancers. 2019; 11(2):152.
https://doi.org/10.3390/cancers11020152
Chicago/Turabian Style
Fountain, Eric, Roland L. Bassett, Suzanne Cain, Liberty Posada, Dan S. Gombos, Patrick Hwu, Agop Bedikian, and Sapna P. Patel.
2019. "Adjuvant Ipilimumab in High-Risk Uveal Melanoma" Cancers 11, no. 2: 152.
https://doi.org/10.3390/cancers11020152
APA Style
Fountain, E., Bassett, R. L., Cain, S., Posada, L., Gombos, D. S., Hwu, P., Bedikian, A., & Patel, S. P.
(2019). Adjuvant Ipilimumab in High-Risk Uveal Melanoma. Cancers, 11(2), 152.
https://doi.org/10.3390/cancers11020152